Evidence map›Paper›PMID 41090127›Full record

ArticleFrontiers in medicine2025

Case Report: Papillophlebitis associated with MOG-IgG-associated optic neuritis.

Yuanmin Dai, Siran Zhang, Yue Lou

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yuanmin DaiDepartment of Ophthalmology, Zhejiang Hospital, Hangzhou, Zhejiang, China.
Siran ZhangDepartment of Neurology, Zhejiang Hospital, Hangzhou, Zhejiang, China.
Yue LouDepartment of Neurology, Zhejiang Hospital, Hangzhou, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optic neuritis is a common manifestation in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). However, its association with papillophlebitis is rare and has only been sporadically reported in the literature. Papillophlebitis is primarily characterized by central retinal vein occlusion (CRVO) and typically affects young to middle-aged adults. We present the case of a 27-year-old woman who initially presented to the emergency department with headache, fever, and seizures. During her hospitalization, MOGAD was diagnosed based on brain MRI, cerebrospinal fluid analysis, and serological testing. Following the initiation of systemic corticosteroid therapy, bilateral optic neuritis was observed. One month later, the patient reported decreased vision in her left eye. Multimodal retinal imaging revealed tortuous retinal veins, flame-shaped hemorrhages, macular edema, and mild leakage from the optic disk and retinal vessels on fluorescein angiography (FA). Genetic testing identified homozygous MTHFR (C665T) and heterozygous PAI-1 (4G/5G) mutations, which supported the diagnosis of papillophlebitis. The patient's vision improved following intravitreal anti-VEGF therapy. To the best of our knowledge, this is the first reported case of papillophlebitis occurring as a secondary complication of MOG-associated optic neuritis. This finding provides new insight into the spectrum of MOGAD and underscores the importance of regular fundus examinations during treatment to facilitate the timely management of ocular complications.

Indexed as

central retinal vein occlusionencephalitisoptic neuritispapillophlebitisranibizumab

Identifiers

PMID41090127
PMCPMC12515929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.